Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Neurochemistry Congress 2018

About Conference


ConferenceSeries Ltd is a renowned organization that organizes highly notable pharmaceutical, Chemistry and other Life Sciences conferences throughout the globe. ConferenceSeries Ltd organizes 600+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contain over 70000 eminent personalities, reputed scientists as editorial board members, 1200 Symposium & Workshops and 5 million followers.

To know more about the conference series visithttp://www.conferenceseries.com/

ConferenceSeries Ltd  invites all the participants from all over the world to attend 25th International Conference on Neurochemistry and Neuropharmacology during July 02-03, 2018 in Thailand, Bangkok which includes prompt keynote presentations, Oral talks, Poster presentations, Workshops and Exhibitions.

Why to attend???

With members from around the world focused on learning about neuropharmacology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Neurochemistry & Neuropharmacology community conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Neurochemistry & Neuropharmacology are hallmarks of this conference.

      Target Audience:

  • Neurochemistry Students
  • Neurochemistry Scientists
  • Neurochemistry Researchers
  • Neurochemistry  Faculty
  • Medical Colleges
  • Neurochemistry Associations and Societies
  • Manufacturing Medical Devices Companies
  • Neuropharmacology Students
  • Neuropharmacology Scientists
  • Neuropharmacology Researchers
  • Neuropharmacology Faculty
  • Medical Colleges
  • Neuropharmacology Associations and Societies
  • Business Entrepreneurs
  • Training Institutes

2018 Highlights:

  • 300+ Participation (70 Industry: 30 Academia)
  • 5+ Keynote Speakers
  • 50+ Plenary Speakers
  • 20+ Exhibitors
  • 14 Innovative Educational Sessions
  • 5+ Workshops
  • B2B Meetings

Sessions/Tracks

Track 1: Neurochemistry

Neurochemistry deals with the processes happening in nervous system and nerve tissues. One of these processes is Neurotransmission, wherein, the interaction at the synapse occurs with the help of neurotransmitters such as Dopamine, Acetylcholine, Norepinephrine, Glutamate,  Serotonin, Gamma-aminobutyric acid (GABA), Endogenous opioids etc. Activity of ion channels assists neurotransmitter receptors to receive the signals. This mechanism is altered by the many drugs, as a treatment process of neurological disorders.

The global sales of drugs to treat progressive dementia with other neurological abnormalities expected to reach $537.2 million in 2012 and $913.7 million by 2017, at a CAGR of 11.2% over the five-year forecast period. These are the chemicals introduced into the Photo switchable ligands into ion channels stirrups the possible ways of diverse roles of neurotransmitters and receptors in the nervous system.

Related Neurochemistry Conferences | Neuroscience Conferences | Neurology Conferences | Neuropharmacology Conferences

17th Global Neuroscience Conference, October 16-17, 2017 Osaka, Japan; 12th Global Neurologists Conference and Neurology Conference, May 17-18, 2018, Singapore; 21st World Congress on Neurology and Therapeutics March 15-17, 2018 London;  3rd International conference on Neurological disorders and stroke April 24-25, 2017 Dubai, UAE;  9th Global Experts Meeting on Neuropharmacology June 18-19, 2018 Paris, France; 25th World Congress on Neurology and Neurodisorders July 16-17, 2018 Melbourne, Australia; 12th Global Neurologists Annual Meeting on Neurology and Neuro Surgery May 17-18, 2018 Singapore; Global Neuropharmacology and Neurochemistry Congress October 1-2, 2018 Los Angeles, CA, USA; 8th International conference on Neuropharmaceutics and Neuropharmacology October 8-10, 2018 Scotland; The British Neuroscience Association Festival of Neuroscience 10-13 April 2017 Birmingham, UK.

American Society for Neurochemistry; International Society for Neurochemistry Inc. ; Asian Pacific Society for Neurochemistry; ISN International Society for Neurochemistry

Track 2: Neuropharmacology

The neuropharmacology will discuss the drug-induced changes in functioning of the nervous system. The specific focus of this course will be to provide a description of the cellular and molecular actions of drugs on synaptic transmission. This course will also refer to specific diseases of the nervous system and their treatment in addition to giving an overview of the techniques used for the study of neuropharmacology.

Related Neurochemistry Conferences | Neuroscience Conferences | Neurology Conferences | Neuropharmacology Conferences

17th Global Neuroscience Conference, October 16-17, 2017 Osaka, Japan; 12th Global Neurologists Conference and Neurology Conference, May 17-18, 2018, Singapore; 21st World Congress on Neurology and Therapeutics March 15-17, 2018 London;  3rd International conference on Neurological disorders and stroke April 24-25, 2017 Dubai, UAE;  9th Global Experts Meeting on Neuropharmacology June 18-19, 2018 Paris, France; 25th World Congress on Neurology and Neurodisorders July 16-17, 2018 Melbourne, Australia; 12th Global Neurologists Annual Meeting on Neurology and Neuro Surgery May 17-18, 2018 Singapore; Global Neuropharmacology and Neurochemistry Congress October 1-2, 2018 Los Angeles, CA, USA; 8th International conference on Neuropharmaceutics and Neuropharmacology October 8-10, 2018 Scotland; The British Neuroscience Association Festival of Neuroscience 10-13 April 2017 Birmingham, UK.

British Pharmacological Society ; The Canadian Society of Pharmacology and Therapeutics ; American Society for Pharmacology and Experimental Therapeutics ; Indonesia Veterinary Pharmacy and Pharmacology Association; American Society of Clinical Pharmacology & Therapeutics; British Association for Psychopharmacology ; European Association for Clinical Pharmacology and Therapeutics ; Indian Pharmacological Society

Track 3: Neuroscience

The human brain remains a great mystery in science and current research strives to understand molecular and cellular processes of the nervous system. Prevention and effective treatment of neurological disorders like Alzheimer's and Parkinson's diseases has been a major medical challenge. Neurology is the enclosure of medical research and practices that devoirs disorders and issues of the nervous system, including the brain. Doctors specialized in diagnosing patients and their problems whereas neurology nurses are one who trained to aid these doctors in the treatment of patients with neurological issues. Neurology nurse deals with giving both post-operative care and immediate care. Various conditions Like Parkinson’s disease, brain tumours, encephalitis, multiple sclerosis and meningitis, as well as those who have suffered from trauma, such as neurology victims and those who have had spinal or brain.

Related Neurochemistry Conferences | Neuroscience Conferences | Neurology Conferences | Neuropharmacology Conferences

17th Global Neuroscience Conference, October 16-17, 2017 Osaka, Japan; 12th Global Neurologists Conference and Neurology Conference, May 17-18, 2018, Singapore; 21st World Congress on Neurology and Therapeutics March 15-17, 2018 London;  3rd International conference on Neurological disorders and stroke April 24-25, 2017 Dubai, UAE;  9th Global Experts Meeting on Neuropharmacology June 18-19, 2018 Paris, France; 25th World Congress on Neurology and Neurodisorders July 16-17, 2018 Melbourne, Australia; 12th Global Neurologists Annual Meeting on Neurology and Neuro Surgery May 17-18, 2018 Singapore; Global Neuropharmacology and Neurochemistry Congress October 1-2, 2018 Los Angeles, CA, USA; 8th International conference on Neuropharmaceutics and Neuropharmacology October 8-10, 2018 Scotland; The British Neuroscience Association Festival of Neuroscience 10-13 April 2017 Birmingham, UK.

Society for Neuroscience ; Cognitive Neuroscience Society ; The International Behavioral Neuroscience Society (IBNS) ; The British Neuroscience Association (BNA) ; Canadian Association for Neuroscience.

Track 4: Neurological Disorders

The brain, spinal cord, and nerves make up the nervous system. Together they control all the workings of the body. When something goes wrong with a part of your nervous system, you can have trouble moving, speaking, swallowing, breathing, or learning. You can also have problems with your memory, senses, or mood.

Related Neurochemistry Conferences | Neuroscience Conferences | Neurology Conferences | Neuropharmacology Conferences

17th Global Neuroscience Conference, October 16-17, 2017 Osaka, Japan; 12th Global Neurologists Conference and Neurology Conference, May 17-18, 2018, Singapore; 21st World Congress on Neurology and Therapeutics March 15-17, 2018 London;  3rd International conference on Neurological disorders and stroke April 24-25, 2017 Dubai, UAE;  9th Global Experts Meeting on Neuropharmacology June 18-19, 2018 Paris, France; 25th World Congress on Neurology and Neurodisorders July 16-17, 2018 Melbourne, Australia; 12th Global Neurologists Annual Meeting on Neurology and Neuro Surgery May 17-18, 2018 Singapore; Global Neuropharmacology and Neurochemistry Congress October 1-2, 2018 Los Angeles, CA, USA; 8th International conference on Neuropharmaceutics and Neuropharmacology October 8-10, 2018 Scotland; The British Neuroscience Association Festival of Neuroscience 10-13 April 2017 Birmingham, UK.

European Federation of Neurological Associations (EFNA) ; National Institute of Neurological Disorders and Stroke (NINDS) ; International Parkinson and Movement Disorder Society ; The ASEAN Neurosurgical Society ; The Alzheimer's Disease Association (ADA) .

 Track-5: Brain Disorder

A neurological disorder is any disorder of the nervous system Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Examples of symptoms include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain and altered levels of consciousness. There are many recognized neurological disorders, some relatively common, but many rare. They may be assessed by neurological examination, and studied and treated within the specialties of Neurology and clinical Neuropsychology.

Related Neuroradiology Conferences  |   Neurochemistry Conferences | Neuroscience Conferences | Neurology Conferences | Neuropharmacology Conferences

4th Global Experts Meeting on Parkinson’s & Movement Disorders May 17-18, 2018 Singapore; 17th Global Neuroscience Conference, October 16-17, 2017 Osaka, Japan; 12th Global Neurologists Conference and Neurology Conference, May 17-18, 2018, Singapore; 21st World Congress on Neurology  and Therapeutics March 15-17, 2018 London;  3rd International conference on Neurological disorders and stroke April 24-25, 2017 Dubai, UAE;  9th Global Experts Meeting on Neuropharmacology June 18-19, 2018 Paris, France; 25th World Congress on Neurology and Neurodisorders July 16-17, 2018 Melbourne, Australia; 12th Global Neurologists Annual Meeting on Neurology and Neuro Surgery May 17-18, 2018 Singapore; Global Neuropharmacology and Neurochemistry Congress October 1-2, 2018 Los Angeles, CA, USA; 8th International conference on Neuropharmaceutics and Neuropharmacology October 8-10, 2018 Scotland; The British Neuroscience Association Festival of Neuroscience 10-13 April 2017 Birmingham, UK.

Acoustic Neuroma Association and ADA Disability and Business Technical Assistance Program; Aicardi Syndrome Foundation and Alliance for Aging Research; ALS Association and ALS Therapy Development Institute; International Brain Research Organisation (IBRO); International Child Neurology Association (ICNA); World Federation of Neurology (WFN); World Federation for Neuro Rehabilitation (WFNR); World Federation of Neurosurgical Societies (WFNS); World Psychiatric Association (WPA); Alzheimer's Disease International (ADI) ; Association of Parkinsonism and Related Disorders (APRD)

Track-6: Addiction

A Physical or psychological need for a habit-forming substance, such as a drug or alcohol. In physical addiction, the body adapts to the substance being used and gradually requires increased amounts to reproduce the effects originally produced by smaller doses. See more at withdrawal. In physical addiction, the body adapts to the substance being used and gradually requires increased amounts to reproduce the effects originally produced by smaller doses. See more at withdrawal.

 Addiction is characterized by inability to consistently abstain, impairment in behavioral control and craving, diminished recognition of significant problems with one’s behaviors and interpersonal relationships, and a dysfunctional emotional response. Like other chronic diseases, often involves cycles of relapse and remission. Without treatment or engagement in recovery activities, addiction is progressive and can result in disability or premature death

Related conferences   Addiction Conference | Addiction Therapy Conference | Alcoholism Conference | Substance Abuse Conference | Psychology Events | Psychiatry Conferences | Neurology Conference |

8th International Conference on Addictive Disorders and Alcoholism May 17-18, 2018 Singapore; Australian and New Zealand Addiction Conference May 28-30 ,2018, QT Gold Coast, Australia; ICATT 2018 : 20th International Conference on Addiction Treatment and Therapy June 11 - 12, 2018, Copenhagen, Denmark; The ASAM 49th Annual Conference innovations in Addiction medicine and Science April 12-15, 2018, San Diego, CA,USA; 29th World Summit on Positive PsychologyMindfulness & Psychotherapy which will be held during May21-22,2018 New York, USA; 8th International Conference n AddictiveDisorders and Alcoholism during May 17-18, 2018 at Singapore25th International Conference on Psychiatric Disorders Psychosomatic Medicine ,March 21-22, 2018 Bali, Indonesia; 5th International Conference on Spine and Spinal Disorders, November 5-6,2018San Franciso, USA; National Rx Drug Abuse &Heroin Summit April 2-5,2018 Atlanta, Georgia

American Society of Addiction Medicine (ASAM) ; American Psychological Association (APA);American Addiction Treatment Association (AATA); National Association of Addiction Treatment Providers(NAATP); Texas Association of Addiction Professionals (TAAP); National Association of Alcohol and Drug Abuse Counselors(NAADAC); Missouri Addiction Counselors Association(MACA).

Track-7: Cognitive Neuroscience

The branch of Neuroscience that deals with the way neurological mechanisms are involved in thinking and behavior. Cognitive Neuroscience is an academic field that studies the biological factors (substrates) that underlie and are the bases for cognition (thought and understanding). More simply put, it is the study of how the physical brain and nervous system combine with the body, mind, intellect and other intangible factors of life to create patterns of thought and behavior.

Related Neuropsychiatry Conference |   Neurochemistry Conferences | Neuroscience Conferences | Neurology Conferences | Neuropharmacology Conferences

17th Global Neuroscience Conference October 16-17, 2017 Osaka, Japan; 17th Global Neuroscience Conference, October 16-17, 2017 Osaka, Japan; 12th Global Neurologists Conference and Neurology Conference, May 17-18, 2018, Singapore; 21st World Congress on Neurology and Therapeutics March 15-17, 2018 London;  3rd International conference on Neurological disorders and stroke April 24-25, 2017 Dubai, UAE;  9th Global Experts Meeting on Neuropharmacology June 18-19, 2018 Paris, France; 25th World Congress on Neurology and Neurodisorders July 16-17, 2018 Melbourne, Australia; 12th Global Neurologists Annual Meeting on Neurology and Neuro Surgery May 17-18, 2018 Singapore; Global Neuropharmacology and Neurochemistry Congress October 1-2, 2018 Los Angeles, CA, USA; 8th International conference on Neuropharmaceutics and Neuropharmacology October 8-10, 2018 Scotland; The British Neuroscience Association Festival of Neuroscience 10-13 April 2017 Birmingham, UK.

Cognitive Neuroscience Society ; Association for Psychological Science (APS) ; Australasian Cognitive Neuroscience Society (ACNS) ; British Association for Cognitive Neuroscience

Track-8: Addiction Induced Brain Disorder

Addiction is a chronic brain disorder and not simply a behavior problem involving alcohol, drugs, gambling or sex, experts contend in a new definition of addiction, one that is not solely related to problematic substance abuse. When a drug user has a mental illness prior to drug use, it may be hard to identify symptoms that are exclusively due to the drug use itself. Most symptoms, if the condition is unrelated to drugs, will continue after abstinence from the drug. The opposite is true for drug-induced Disorders; the schizophrenic-like effects will more or less subside after the drug wears off. However, this is not true for all drug users as frequent and prolonged use can cause side effects that last up to years after use discontinue

Drugs like cocaine, cannabis, and hallucinogens can cause mental health problems and, when paired with a pre-existing mental illness, can exacerbate the symptoms of such illnesses. Some drugs, when taken frequently for long periods of time, can actually manifest as psychotic symptoms indicative of schizophrenia and bipolar disorder.

Related Central Nervous system Conferences | Neuropsychiatry Conference |   Neurochemistry Conferences | Neuroscience Conferences | Neurology Conferences | Neuropharmacology Conferences

4th International Conference on Neurological Disorders & Stroke April 19-20, 2018 Dubai, UAE; 17th Global Neuroscience Conference October 16-17, 2017 Osaka, Japan; 17th Global Neuroscience Conference, October 16-17, 2017 Osaka, Japan; 12th Global Neurologists Conference and Neurology Conference, May 17-18, 2018, Singapore; 21st World Congress on Neurology and Therapeutics March 15-17, 2018 London;  3rd International conference on Neurological disorders and stroke April 24-25, 2017 Dubai, UAE;  9th Global Experts Meeting on Neuropharmacology June 18-19, 2018 Paris, France; 25th World Congress on Neurology and Neurodisorders July 16-17, 2018 Melbourne, Australia; 12th Global Neurologists Annual Meeting on Neurology and Neuro Surgery May 17-18, 2018 Singapore; Global Neuropharmacology and Neurochemistry Congress October 1-2, 2018 Los Angeles, CA, USA; 8th International conference on Neuropharmaceutics and Neuropharmacology October 8-10, 2018 Scotland.

American Society of Addiction Medicine (ASAM) ; American Psychological Association (APA);American Addiction Treatment Association (AATA); National Association of Addiction Treatment Providers(NAATP); Texas Association of Addiction Professionals (TAAP); National Association of Alcohol and Drug Abuse Counselors(NAADAC); Missouri Addiction Counselors Association(MACA).

 Track-9: Clinical Interventions & Case Reports

Sharing individual patient experiences with clinical colleagues is an essential component of learning from each other. However, the basic definition of a case report is the detailed report of an individual including aspects like exposure, symptoms, signs, intervention, and outcome. In 1800s and early 1900s, individuals dependent on opioids were primarily developed and from middle socioeconomic groups. However, since the 2000s, minorities and lower socioeconomic groups have been recognized with Opioid dependence. It shows availability of opioids and subcultural factors in opioid use. Therefore, medical professionals are at higher risk for developing opioid-related disorders.

  • Mental Health
  • Emotional health
  • Behavioral health sciences
  • Spiritual sciences
  • Psychology and Education
  • Motivational interviewing
  • Contingency management
  • Residential treatment
  • Psychodynamic therapy
  • Dialectical behavioral therapy
  • Cognitive impairment

Related Neurochemistry Conferences | Neuroscience Conferences | Neurology Conferences | Neuropharmacology Conferences

17th Global Neuroscience Conference, October 16-17, 2017 Osaka, Japan; 12th Global Neurologists Conference and Neurology Conference, May 17-18, 2018, Singapore; 21st World Congress on Neurology

and Therapeutics March 15-17, 2018 London;  3rd International conference on Neurological disorders and stroke April 24-25, 2017 Dubai, UAE;  9th Global Experts Meeting on Neuropharmacology June 18-19, 2018 Paris, France; 25th World Congress on Neurology and Neurodisorders July 16-17, 2018 Melbourne, Australia; 12th Global Neurologists Annual Meeting on Neurology and Neuro Surgery May 17-18, 2018 Singapore; Global Neuropharmacology and Neurochemistry Congress October 1-2, 2018 Los Angeles, CA, USA; 8th International conference on Neuropharmaceutics and Neuropharmacology October 8-10, 2018 Scotland; The British Neuroscience Association Festival of Neuroscience 10-13 April 2017 Birmingham, UK.

Track 10:Neuromuscular Disorders

Neuromuscular disorders affect the nerves that control your voluntary muscles. Voluntary muscles are the ones you can control, like in your arms and legs. Your nerve cells, also called neurons, send the messages that control these muscles. When the neurons become unhealthy or die, communication between your nervous system and muscles breaks down. As a result, your muscles weaken and waste away. The weakness can lead to twitching, cramps, aches and pains, and joint and movement problems. Sometimes it also affects heart function and your ability to breathe.

Examples of neuromuscular disorders include

Many neuromuscular diseases are genetic, which means they run in families or there is a mutation in your genes. Sometimes, an immune system disorder can cause them. Most of them have no cure. The goal of treatment is to improve symptoms, increase mobility and lengthen life.

 

Related Neurochemistry Conferences | Neuroscience Conferences | Neurology Conferences | Neuropharmacology Conferences

17th Global Neuroscience Conference, October 16-17, 2017 Osaka, Japan; 12th Global Neurologists Conference and Neurology Conference, May 17-18, 2018, Singapore; 21st World Congress on Neurology and Therapeutics March 15-17, 2018 London;  3rd International conference on Neurological disorders and stroke April 24-25, 2017 Dubai, UAE;  9th Global Experts Meeting on Neuropharmacology June 18-19, 2018 Paris, France; 25th World Congress on Neurology and Neurodisorders July 16-17, 2018 Melbourne, Australia; 12th Global Neurologists Annual Meeting on Neurology and Neuro Surgery May 17-18, 2018 Singapore; Global Neuropharmacology and Neurochemistry Congress October 1-2, 2018 Los Angeles, CA, USA; 8th International conference on Neuropharmaceutics and Neuropharmacology October 8-10, 2018 Scotland; The British Neuroscience Association Festival of Neuroscience 10-13 April 2017 Birmingham, UK.

EAMDA - European Alliance of Neuromuscular Disorders Associations  ;  American Association of Neuromuscular & Electrodiagnostic Medicine -AANEM ; Hungarian Neuromuscular Disorders Associations ; European Alliance of Neuromuscular Disorders Associations

Track-11: Depression and Anxiety

Losing a loved one, getting fired from a job, going through a divorce, and other difficult situations can lead a person to feel sad, lonely and scared. These feelings are normal reactions to life's stressors. Most people feel low and sad at times. However, in the case of individuals who are diagnosed with depression as a psychiatric disorder, the manifestations of the low mood are much more severe and they tend to persist. Depression occurs more often in women than men. Some differences in the manner in which the depressed mood manifests has been found based on sex and age. In men it manifests often as tiredness, irritability and anger. They may show more reckless behavior and abuse drugs and alcohol. They also tend to not recognize that they are depressed and fail to seek help. In women depression tends to manifest as sadness, worthlessness, and guilt. In younger children depression is more likely to manifest as school refusal, anxiety when separated from parents, and worry about parents dying. Depressed teenagers tend to be irritable, sulky, and get into trouble in school. They also frequently have co-morbid anxiety, eating disorders, or substance abuse. In older adults depression may manifest more subtly as they tend to be less likely to admit to feelings of sadness or grief and medical illnesses which are more common in this population also contributes or causes the depression.

Related   Mindfulness conferences | Psychiatry conferences | Stress conferences

International Conference on Psychotherapy and Psychological Disorders July 11-12, 2018 Toronto, Ontario, Canada; 25th World Summit on Psychology, Psychiatry & Psychotherapy October 19-20, 2017 San Francisco, California, USA;  International Conference on Applied Psychology and Behavioral Medicine Applied Psychology and Behavioral Medicine July 11-12, 2018 Toronto, Ontario, Canada; 4th International Conference on Mental Health and Primary care October 16-17, 2017 Toronto, Canada; 4th International Conference on Depression, Anxiety and Stress Management May 10-11, 2018 Frankfurt, Germany.

Anxiety and Depression Association of America, ADAA ; (MADO) Mood Disorder Association of Ontario ; American Psychological Association .

Track12: Neurosurgery

 Neurosurgery is the surgical specialization that treats diseases and disorders of the brain and spinal cord. Back pain can sometimes produce neurological symptoms such as numbness, muscle weakness, and loss of bowel and bladder control due to dysfunction at the nerve root.

These symptoms are indicators that neurosurgery is required to treat the underlying cause of back pain as opposed to conservative treatments. Procedures to treat back pain under the realm of neurosurgery include discectomy, laminectomy, and spinal fusion surgery.

In neurosurgery, there is a higher risk of further nerve damage and infection which may result in paralysis.

Related Neurology Conferences | Neuroscience Conferences | Neuroradiology Conferences | Brain Disorders Conferences | Neuroimaging Conferences

12th   Global Neurologists Annual Meeting on Neurology and   Neuro Surgery May 17-18, 2018   Singapore; 3rd International conference on Neuroradiology & Imaging May 30-31, 2018 Osaka, Japan Neuroscience, Neuroimaging & Interventional Radiology Oct 30 - Nov 01, 2017 San Antonio, USA; 5th International Conference on Brain Disorders and Therapeutics Brain Disorders and Therapeutics; 23rd International Conference on Neurology and Neurosurgery April 23-25, 2018 Rome, Italy.

American Academy of Neurological and Orthopaedic Surgeons (AANOS) ; American Association of Neurological Surgeons (AANS) ; American Board of Neurological Surgery (ABNS); American Board of Pediatric Neurological Surgery (ABPNS) ; Association of Neurosurgical Physician Assistants (ANSPA) ; Congress of Neurological Surgeons (CNS) ; European Association of Neurosurgical Societies (EANS) ; North American Neuro-Ophthalmology Society (NANOS) ; Society of British Neurological Surgeons (SBNS) - United Kingdom (UK) ; Society of Chinese American Neurological Surgeons (SCANS) ; Women In Neurosurgery (WINS) .

 

Market Analysis

Past Conference Report

To Collaborate Scientific Professionals around the World

Conference Date July 02-03, 2018

Speaker Opportunity

Supported By

Neurochemistry & Neuropharmacology Journal of Neurology & Neurophysiology Journal of Neurology and Neuroscience

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by